Skip to main navigation Skip to search Skip to main content

Erythropoietin and Brain Magnetic Resonance Imaging Findings in Hypoxic-Ischemic Encephalopathy: Volume of Acute Brain Injury and 1-Year Neurodevelopmental Outcome

  • Sarah B. Mulkey
  • , Raghu H. Ramakrishnaiah
  • , Robert C. McKinstry
  • , Taeun Chang
  • , Amit M. Mathur
  • , Dennis E. Mayock
  • , Krisa P. Van Meurs
  • , G. Bradley Schaefer
  • , Chunqiao Luo
  • , Shasha Bai
  • , Sandra E. Juul
  • , Yvonne W. Wu

Research output: Contribution to journalArticlepeer-review

Abstract

In the Neonatal Erythropoietin and Therapeutic Hypothermia Outcomes study, 9/20 erythropoietin-treated vs 12/24 placebo-treated infants with hypoxic-ischemic encephalopathy had acute brain injury. Among infants with acute brain injury, the injury volume was lower in the erythropoietin than the placebo group (P =.004). Higher injury volume correlated with lower 12-month neurodevelopmental scores. Trial registration ClinicalTrials.gov: NCT01913340.

Original languageEnglish
Pages (from-to)196-199
Number of pages4
JournalJournal of Pediatrics
Volume186
DOIs
StatePublished - Jul 2017

Keywords

  • brain volumetrics
  • diffusion weighted imaging
  • neuroprotection
  • newborn

Fingerprint

Dive into the research topics of 'Erythropoietin and Brain Magnetic Resonance Imaging Findings in Hypoxic-Ischemic Encephalopathy: Volume of Acute Brain Injury and 1-Year Neurodevelopmental Outcome'. Together they form a unique fingerprint.

Cite this